A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility
- PMID: 7458567
- DOI: 10.1001/archpsyc.1981.01780260017001
A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility
Abstract
Four hundred thirty-eight subjects underwent an overnight dexamethasone suppression test (DST) to standardize the test for the diagnosis of melancholia (endogenous depression). Abnormal plasma cortisol concentrations within 24 hours after dexamethasone administration occurred almost exclusively in melancholic patients. The best plasma cortisol criterion concentration, above which a DST result may be considered abnormal, was 5 microgram/dL. The optimal dose of dexamethasone was 1 rather than 2 mg. Two blood samples obtained at 4 and 11 PM after dexamethasone administration detected 98% of the abnormal test results. This version of the DST identified melancholic patients with a sensitivity of 67% and a specificity of 96%. Baseline nocturnal plasma cortisol concentrations were not useful. Abnormal DST results were found with similar frequency among outpatients and inpatients with melancholia; but they were not related to age, sex, recent use of psychotropic drugs, or severity of depressive symptoms. Extensive evidence validates this practical test for the diagnosis of melancholia.
Similar articles
-
Comparison of plasma cortisol and corticosterone in the dexamethasone suppression test for melancholia.Psychoneuroendocrinology. 1984;9(1):45-55. doi: 10.1016/0306-4530(84)90021-0. Psychoneuroendocrinology. 1984. PMID: 6739664
-
The dexamethasone suppression test in patients with mood disorders.J Clin Psychiatry. 1996 Oct;57(10):470-84. doi: 10.4088/jcp.v57n1006. J Clin Psychiatry. 1996. PMID: 8909334 Review.
-
Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia.Biol Psychiatry. 1986 May;21(5-6):436-44. doi: 10.1016/0006-3223(86)90185-x. Biol Psychiatry. 1986. PMID: 3697434
-
Specificity of the salivary cortisol dexamethasone suppression test across psychiatric diagnoses.Biol Psychiatry. 1989 Apr 1;25(7):879-93. doi: 10.1016/0006-3223(89)90268-0. Biol Psychiatry. 1989. PMID: 2720003
-
[Low-dose (0.5 mg) DST in manic and major depressive episodes: in relation to the severity of symptoms].Seishin Shinkeigaku Zasshi. 2000;102(4):367-98. Seishin Shinkeigaku Zasshi. 2000. PMID: 10892305 Review. Japanese.
Cited by
-
The Hypothalamic-Pituitary-Adrenal Axis in Major Depressive Disorder: A Brief Primer for Primary Care Physicians.Prim Care Companion J Clin Psychiatry. 2001 Aug;3(4):151-155. doi: 10.4088/pcc.v03n0401. Prim Care Companion J Clin Psychiatry. 2001. PMID: 15014598 Free PMC article.
-
On the relation among psychological distress, diabetes-related health behavior, and level of glycosylated hemoglobin in type I diabetes.Int J Behav Med. 1995;2(2):104-17. doi: 10.1207/s15327558ijbm0202_2. Int J Behav Med. 1995. PMID: 16250780
-
Salivary alpha-amylase and cortisol responsiveness following electrically stimulated physical stress in bipolar disorder patients.Neuropsychiatr Dis Treat. 2013;9:1899-905. doi: 10.2147/NDT.S48722. Epub 2013 Dec 6. Neuropsychiatr Dis Treat. 2013. PMID: 24353422 Free PMC article.
-
DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression.PLoS One. 2011;6(8):e23881. doi: 10.1371/journal.pone.0023881. Epub 2011 Aug 30. PLoS One. 2011. PMID: 21912609 Free PMC article.
-
In search of HPA axis dysregulation in child and adolescent depression.Clin Child Fam Psychol Rev. 2011 Jun;14(2):135-60. doi: 10.1007/s10567-011-0084-5. Clin Child Fam Psychol Rev. 2011. PMID: 21290178 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical